The propeptide of Fasciola hepatica cathepsin L is a potent and selective inhibitor of the mature enzyme

Molecular and Biochemical Parasitology

Volumn 98, Issue 2, 1999, Pages 271-277

  Roche, Leda ^a,b   Tort, Jose ^a,b   Dalton, John P ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

Fasciola hepatica; Inhibitor; Propeptide; Proteinase; Trematode

Indexed keywords

CATHEPSIN L; CYSTEINE PROTEINASE; PROTEIN PRECURSOR; RECOMBINANT ENZYME;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; ENZYME ASSAY; ENZYME PURIFICATION; FASCIOLA HEPATICA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENDOPEPTIDASES; ENZYME PRECURSORS; FASCIOLA HEPATICA; MOLECULAR SEQUENCE DATA; PAPAIN;

ANIMALIA; FASCIOLA HEPATICA; HEPATICA; TREMATODA;

EID: 0032980694     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(98)00164-9     Document Type: Article

References (22)

1. Coulombe R., Grochulski P., Sivaraman J., Menard R., Mort J.S., Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15:1996;5492-5503.
2. Shinde U.P., Lui J.J., Inouye M. Protein memory through altered folding mediated by intramolecular chaperones. Nature. 389:1997;520-522.
3. Baker D., Silen J.L., Agard D.A. Protease proregion required for folding is a potent inhibitor of the mature enzyme. Protein Struct. Funct. Genet. 12:1992;339-344.
4. Fox T., de Miguel E., Mort J.S., Storer A.C. Potent slow-binding inhibition of the cathepsin B by its propeptide. Biochemistry. 31:1992;12571-12576.
5. Taylor M.A., Baker K.C., Briggs G.S., Connerton I.F., Cummings N.J., Pratt K.A., Revell D.F., Freedman R.B., Goodenough P.T. Recombinant pro-regions from papain and papaya proteinase IV are selective high affinity inhibitors of the mature papaya enzymes. Protein Eng. 8:1995;59-62.
6. Carmona E., Dufour E., Plouffe C., Takebe S., Mason P., Mort J.S., Menard R. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry. 35:1996;8149-8157.
7. Dalton J.P., Brindley P.J. Proteases of Trematodes. Fried B., Graczyk T.K. Advances in Trematode Biology. 1997;CRC Press, Boca Raton, New York.
8. Roche L., Dowd A.J., Tort J., McGonigle S., McSweeney A., Curley P., Ryan T., Dalton J.P. Functional expression of Fasciola hepatica Cathepsin L1 in Saccharomyces cerevisiae. Eur. J. Biochem. 245:1997;373-380.
9. Dalton J.P., Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Mol. Biochem. Parasitol. 35:1989;161-166.
10. Smith A.M., Dowd A.J., McGonigle S., Keegan P.S., Brennan G., Trudgett A., Dalton J.P. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol. Biochem. Parasitol. 62:1993;1-8.
11. Dalton J.P., Clough K.M., Jones M.K., Brindley P.J. Characterisation of the cathepsin-like proteinases of Schistosoma mansoni. Infect. Immun. 64:1996;1328-1334.
12. Dowd A.J., Tort J., Roche L., Ryan T., Dalton J.P. Isolation of a cDNA encoding Fasciola hepatica cathepsin L2 and functional expression in Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 88:1997;163-174.
13. Barrett A.J., Kirschke H. Cathepsin B, Cathepsin H, Cathepsin L. Method. Enzymol. 80:1981;535-580.
14. Izquierdo-Martin M., Stein R.L. Transition-state features for the association of metalloproteases with phosphorous-containing inhibitors. J. Am. Chem. Soc. 114:1992;1527-1528.
15. Williams J.W., Morrison J.F. The kinetics of reversible tight binding inhibition. Method. Enzymol. 63:1979;437-467.
16. Dowd A.J., Smith A.M., McGonigle S., Dalton J.P. Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica. Eur. J. Biochem. 223:1994;91-98.
17. Day S.R., Dalton J.P., Clough K.A., Leonardo L., Tiu W.U., Brindley P.J. Characterisation and cloning of the cathepsin L proteinases of Schistosoma japonicum. Biochem. Biophys. Res. Comm. 217:1995;1-9.
18. Cygler M., Sivaraman J., Grochulski P., Coulombe R., Storer A.C., Mort J.S. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. Structure. 4:1996;405-416.
19. Groves M.R., Taylor M.A., Scott M., Cummings N.J., Pickersgill R.W., Jenkins J.A. The prosequence of procaricain forms an alpha-helical domain that prevents access to the substrate-binding cleft. Structure. 4:1996;1193-1203.
20. Maubach G., Schilling K., Rommerskirch W., Wenz I., Schultz J.E., Weber E., Wiederanders B. The inhibition of cathepsin S by its propeptide: specificity and mechanism of action. Eur. J. Biochem. 250:1997;745-750.
21. Dalton J.P., McGonigle S., Rolph T., Andrews S. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and hemoglobin. Infect. Immun. 64:1996;5066-5074.
22. Wasilewsky M.M., Lim K.C., Phillips J., McKerrow J.H. Cysteine protease inhibitors block schistosome haemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol. Biochem. Parasitol. 81:1996;179-189.